| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |